Table 1 Ingenuity Pathway Assist analysis of genes involved in the Aurora-A kinase pathway. Data represents fold enrichment in carcinoma patients versus adenoma patients. *SAM analysis estimated the False Discovery Rate for all genes to be 0.
From: Aurora kinase inhibitors synergize with paclitaxel to induce apoptosis in ovarian cancer cells
Affymetrix Probe ID | Gene | Name | Fold Change |
|---|---|---|---|
39109_at | TPX2 | TPX2, microtubule associated, homolog | 15.42 |
1125_s_at; 1126_s_at | CD44 | CD44 molecule | 4.51 |
36863_at | HMMR | Hyaluronan-mediated motility receptor | 2.73 |
32157_at | PPP1CA | Protein phosphatase 1, catalytic subunit, alpha isoform | 2.46 |
40757_at | GZMA | Granzyme A | 2.26 |
1985_s_at | NME1 | Non-metastatic cells 1 | 2.24 |
38370_at | TIAM1 | T-cell lymphoma invasion and metastasis | 2.18 |